2 Forward-Looking Statements This presentation contains forward-looking statements about GenMark Diagnostics, Inc. These statements involve known and unknown risks that relate to the Company’s future events or future financial performance and the actual results could differ materially from those discussed in this presentation. Factors that may cause the Company's actual results to differ materially from those discussed in the presentation, include: • failure to obtain sufficient funding for the continued development and commercialization of the Company's products; • failure to expand the Company's menu of diagnostic tests, including the failure to obtain licenses to additional biomarkers on commercially reasonable terms; • increases in the Company's projected expenditures on sales and marketing, research and development and administrative activities; • less than anticipated growth in the market for diagnostic testing generally and for the tests the Company is developing or may develop in the future; • failure of the Company's products to gain market acceptance domestically or internationally; • inability to obtain regulatory clearance or approval for any of the Company's products; • changes in the regulatory environment which may adversely impact the commercialization of the Company's new products and result in significant additional capital expenditures; • failure to enter into or maintain successful strategic alliances, which may delay the development or commercialization of the Company's products or may result in significant additional expenditures; • inability to attract or retain skilled personnel for the Company's product development and commercialization efforts; • inability to protect the Company's intellectual property and operate the Company's business without infringing upon the intellectual rights of others, which could result in litigation and significant expenditures; • refusal of third-party payors to reimburse the Company's customers for use of diagnostic systems and tests; and • failure to develop the Company's NexGen System with the capabilities the Company intends to offer. Additional risks and uncertainties relating to the Company and its business can be found in the "Risk Factors" section of GenMark's Form 10-K and other filings with the United States Securities and Exchange Commission. The forward-looking statements contained in this presentation represent the Company’s estimates and assumptions only as of the date of this presentation and the Company undertakes no duty or obligation to update or revise publicly any forward-looking statements contained in this presentation as a result of new information, future events or changes in the Company’s expectations. |